drugset / Trial / NCT01723241

Phase 1 Study of XAF5 Gel Applied to Skin of Healthy Volunteers

NCT01723241 ↗

Phase 1 Completed 32 enrolled Topokine Therapeutics, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study to assess the safety, tolerability, and pharmacokinetics of XAF5 Gel when applied to the skin of healthy volunteers.

Timeline

Start
2012-11
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject XAF5 Unknown — —

Indications

No indication recorded.